today announced upcoming poster presentations including one for CM24 in the treatment of pancreatic cancer, and two for NT219 in the treatment of colorectal and head and neck cancers, at the 2025 ...

today announced four poster presentations at the 2025 American Association for Cancer Research (AACR) Annual Meeting, taking place April 25-30, 2025, in Chicago, IL.

The posters can be accessed through the “Supporting ... experience and capabilities to translate its science to advance research on additional areas of opportunity for azenosertib outside ...

We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not ...

Session Date and Time: April 30, 2025 - 9:00 AM - 12:00 PM CT (10:00 AM - 1:00 PM ET) Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Cogent also announced today that the Compensation Committee ...

Cogent also announced today that the Compensation Committee of Cogent’s Board of Directors, made up entirely of independent directors, approved the grant of an “inducement” equity award on March 21, ...

The posters can be accessed through the “Supporting Publications ... The Company is also leveraging its extensive experience and capabilities to translate its science to advance research on additional ...